Jordan
Industry
BMI View: Lebanon's decision to allow the registration and therefore import of Jordanian medicines presents opportunities for Jordanian firms to expand regionally and also adds an...
2010-05-12Industry
BMI's view on the Jordanian pharmaceutical market is set to hold for the short term - generic drugs will continue to comprise the majority of the drug market owing to the developed...
2010-04-27Industry
Jordan has long been a medical tourism centre for the Middle East and the latest announcement from the Private Hospitals Association (PHA) revealed that there has been a 10% rise...
2010-04-26Industry
The Jordanian healthcare market will reach a value of US$2.7bn by 2014 at a compound annual growth rate of 6.5% in US dollar terms from 2009. Meanwhile, healthcare will account for...
2010-04-19Industry
Jordanian generic drugmaker Hikma has entered into an agreement with South Korean Celltrion to manufacture biosimilars in the Middle East. The development underlines Hikma's strategy...
2010-04-12Industry
Jordanian generic drugmaker Hikma has announced that it plans to purchase additional shares in Tunisian pharmaceutical firm Ibn Al Baytar which will see it accumulate a 66% controlling...
2010-03-31Industry
Jordan's major generic drugmaker Hikma has announced that it plans to increase sales to the 'low teens' from 10% in 2009. Despite its expansion plans within the Middle East, the growth...
2010-03-24Industry
Jordan and Brazil are in discussions to finalise a Free Trade Agreement (FTA) between Jordan and the Mercosur trade bloc, which includes Brazil, Argentina, Uruguay and Paraguay. If...
2010-03-19
